Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

Morphine Tolerance in Spinal Cord Is Due to Interaction between μ- and δ-Receptors

Pal Riba, Yong Ben, Andrew P. Smith, Susanna Furst and Nancy M. Lee
Journal of Pharmacology and Experimental Therapeutics January 2002, 300 (1) 265-272; DOI: https://doi.org/10.1124/jpet.300.1.265
Pal Riba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong Ben
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew P. Smith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanna Furst
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy M. Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

When the opioid agonist morphine is given chronically and systemically to mice by pellet implantation for 3 days, the animals develop substantial tolerance to the antinociceptive effect of a test dose of morphine given systemically. When the test dose is administered to the spinal cord, however, very little tolerance is observed. We tested six strains of mice differing in the degree to which they develop systemic tolerance to morphine and found that none of them developed significant tolerance to spinal morphine. However, most of these strains did develop substantial spinal tolerance to antinociception induced by the selective μ-agonist [d-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) and by the selective δ-agonist [d-Pen2,d-Pen5]-enkephalin (DPDPE). Moreover, in naı̈ve animals, the antinociceptive effect of both DAMGO and DPDPE was blocked byd-Phe-Cys-Tyr-d-Trp-Arg-Thr-Pen-Thr-NH2, a selective μ-antagonist, indicating that both agonists mediate antinociception in the spinal cord through μ-receptors. In addition to directly mediating antinociception, however, DPDPE potentiated the antinociceptive activity of DAMGO in the spinal cord of naı̈ve animals, and this antinociception was blocked by the δ-antagonist H-TyrTicPsi[CH2NH]Phe-Thr-OH (TIPPψ), indicating mediation through δ-receptors. In contrast, in tolerant animals, TIPPψ enhanced the antinociception of DAMGO. These results thus demonstrate not only that μ- and δ-opioid receptors interact in naı̈ve animals, but that the nature of this interaction changes during tolerance, from a potentiation to an inhibition. The lack of tolerance to spinal morphine may result from the ability of morphine to act as a partial antagonist at δ-receptors.

Footnotes

  • This work was supported in part by National Institute on Drug Abuse Grants DA02643 and DA10.

  • Abbreviations

    i.t.
    intrathecal
    CTAP
    d-Phe-Cys-Tyr-d-Trp-Arg-Thr-Pen-Thr-NH2
    DAMGO
    [d-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin
    DPDPE
    [d-Pen2,d-Pen5]-enkephalin
    TIPPψ
    H-TyrTicPsi[CH2NH]Phe-Thr-OH
    • Received July 30, 2001.
    • Accepted September 25, 2001.
    • The American Society for Pharmacology and Experimental Therapeutics
    View Full Text

    JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

    Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

     

    • Click here for information on institutional subscriptions.
    • Click here for information on individual ASPET membership.

     

    Log in using your username and password

    Forgot your user name or password?

    Purchase access

    You may purchase access to this article. This will require you to create an account if you don't already have one.
    PreviousNext
    Back to top

    In this issue

    Journal of Pharmacology and Experimental Therapeutics: 300 (1)
    Journal of Pharmacology and Experimental Therapeutics
    Vol. 300, Issue 1
    1 Jan 2002
    • Table of Contents
    • About the Cover
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Morphine Tolerance in Spinal Cord Is Due to Interaction between μ- and δ-Receptors
    (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
    (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Research ArticleNEUROPHARMACOLOGY

    Morphine Tolerance in Spinal Cord Is Due to Interaction between μ- and δ-Receptors

    Pal Riba, Yong Ben, Andrew P. Smith, Susanna Furst and Nancy M. Lee
    Journal of Pharmacology and Experimental Therapeutics January 1, 2002, 300 (1) 265-272; DOI: https://doi.org/10.1124/jpet.300.1.265

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Research ArticleNEUROPHARMACOLOGY

    Morphine Tolerance in Spinal Cord Is Due to Interaction between μ- and δ-Receptors

    Pal Riba, Yong Ben, Andrew P. Smith, Susanna Furst and Nancy M. Lee
    Journal of Pharmacology and Experimental Therapeutics January 1, 2002, 300 (1) 265-272; DOI: https://doi.org/10.1124/jpet.300.1.265
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Materials and Methods
      • Results
      • Discussion
      • Footnotes
      • Abbreviations
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • CVN424, a novel GPR6 inverse agonist for Parkinson's disease
    • Methylone Brain Concentrations and Pharmacodynamic Effects
    • Oxysterols and Ethanol
    Show more Neuropharmacology

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About JPET
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0103 (Online)

    Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics